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Abstract
A good questionnaire design for a clinical trial will minimise bias and maximise precision in the estimates of treat-
ment effect within budget. Attempts to collect more data than will be analysed may risk reducing recruitment
(reducing power) and increasing losses to follow-up (possibly introducing bias). The mode of administration can
also impact on the cost, quality and completeness of data collected. There is good evidence for design features
that improve data completeness but further research is required to evaluate strategies in clinical trials. Theory-
based guidelines for style, appearance, and layout of self-administered questionnaires have been proposed but
require evaluation.
Introduction
With fixed trial resources there will usually be a trade
off between the number of participants that can be
recruited into a trial and the quality and quantity of
information that can be collected from each participant
[1]. Although half a century ago there was little empiri-
cal evidence for optimal questionnaire design, Bradford
Hill suggested that for every question asked of a study
participant the investigator should be required to answer
three himself, perhaps to encourage the investigator to
keep the number of questions to a minimum [2].
To assess the empirical evidence for how question-
naire length and other design features might influence
data completeness in a clinical trial, a systematic review
of randomised controlled trials (RCTs) was conducted,
and has recently been updated [3]. The strategies found
to be effective in increasing response to postal and elec-
tronic questionnaires are summarised in the section on
increasing data completeness below.
Clinical trial investigators have also relied on princi-
ples of questionnaire design that do not have an estab-
lished empirical basis, but which are nonetheless
considered to present ‘good practice’, based on expert
opinion. The section on questionnaire development
below includes some of that advice and presents general
guidelines for questionnaire development which may
help investigators who are about to design a question-
naire for a clinical trial.
As this paper concerns the collection of outcome data
by questionnaire from trial participants (patients, carers,
relatives or healthcare professionals) it begins by intro-
ducing the regulatory guidelines for data collection in
clinical trials. It does not address the parallel (and
equally important) needs of data management, cleaning,
validation or processing required in the creation of the
final clinical database.
Regulatory guidelines
The International Conference on Harmonisation (ICH)
of technical requirements for registration of pharmaceu-
ticals for human use states:
’The collection of data and transfer of data from the
investigator to the sponsor can take place through a
variety of media, including paper case record forms,
remote site monitoring systems, medical computer sys-
tems and electronic transfer. Whatever data capture
instrument is used, the form and content of the infor-
mation collected should be in full accordance with the
protocol and should be established in advance of the
conduct of the clinical trial. It should focus on the data
necessary to implement the planned analysis, including
the context information (such as timing assessments
relative to dosing) necessary to confirm protocol com-
pliance or identify important protocol deviations. ‘Miss-
ing values’ should be distinguishable from the ‘value
zero’ or ‘characteristic absent’...’ [4].* Correspondence: phil.edwards@LSHTM.ac.uk
Department of Epidemiology and Population Health, London School of
Hygiene and Tropical Medicine, London, UK
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This suggests that the choice of variables that are to
be measured by the questionnaire (or case report form)
is constrained by the trial protocol, but that the mode
of data collection is not. The trial protocol is unlikely,
however, to list all of the variables that may be required
to evaluate the safety of the experimental treatment.
The choice of variables to assess safety will depend on
the possible consequences of treatment, on current
knowledge of possible adverse effects of related treat-
ments, and on the duration of the trial [5]. In drug trials
there may be many possible reactions due to the phar-
macodynamic properties of the drug. The Council for
International Organisations of Medical Sciences
(CIOMS) advises that:
’Safety data that cannot be categorized and succinctly
collected in predefined data fields should be recorded in
the comment section of the case report form when
deemed important in the clinical judgement of the
investigator’ [5].
Safety data can therefore initially be captured on a
questionnaire as text responses to open-ended questions
that will subsequently be coded using a common
adverse event dictionary, such as the Medical Dictionary
for Drug Regulatory Activities (MEDRA). The coding of
text responses should be performed by personnel who
are blinded to treatment allocation. Both ICH and
CIOMS warn against investigators collecting too much
data that will not be analysed, potentially wasting time
and resources, reducing the rate of recruitment, and
increasing losses to follow-up.
Before questionnaire design begins, the trial protocol
should be available at least in draft. This will state
which outcomes are to be measured and which para-
meters are of interest (for example, percentage, mean,
and so on). Preferably, a statistical analysis plan will also
be available that makes explicit how each variable will
be analysed, including how precisely each is to be mea-
sured and how each variable will be categorised in ana-
lysis. If these requirements are known in advance, the
questionnaire can be designed in such a way that will
reduce the need for data to be coded once question-
naires have been completed and returned.
Questionnaire development
If a questionnaire has previously been used in similar
trials to the one planned, its use will bring the added
advantage that the results will be comparable and may
be combined in a meta-analysis. However, if the mode
of administration of the questionnaire will change (for
example, questions developed for administration by per-
sonal interview are to be included in a self-administered
questionnaire), the questionnaire should be piloted
before it is used (see section on piloting below). To
encourage the consistent reporting of serious adverse
events across trials, the CIOMS Working Group has
prepared an example of the format and content of a
possible questionnaire [5].
If a new questionnaire is to be developed, testing will
establish that it measures what is intended to be mea-
sured, and that it does so reliably. The validity of a
questionnaire may be assessed in a reliability study that
assesses the agreement (or correlation) between the out-
come measured using the questionnaire with that mea-
sured using the ‘gold standard’. However, this will not
be possible if there is no recognised gold standard mea-
surement for outcome. The reliability of a questionnaire
may be assessed by quantifying the strength of agree-
ment between the outcomes measured using the ques-
tionnaire on the same patients at different times. The
methods for conducting studies of validity and reliability
are covered in depth elsewhere [6]. If new questions are
to be developed, the reading ease of the questions can
be assessed using the Flesch reading ease score. This
score assesses the number of words in sentences, and
the number syllables in words. Higher Flesch reading
scores indicate material that is easier to read [7].
Types of questions
Open-ended questions offer participants a space into
which they can answer by writing text. These can be
used when there are a large number of possible answers
and it is important to capture all of the detail in the
information provided. If answers are not factual, open-
ended questions might increase the burden on partici-
pants. The text responses will subsequently need to be
reviewed by the investigator, who will (whilst remaining
blind to treatment allocation) assign one or more codes
that categorise the response (for example, applying an
adverse event dictionary) before analysis. Participants
will need sufficient space so that full and accurate infor-
mation can be provided.
Closed-ended questions contain either mutually exclu-
sive response options only, or must include a clear
instruction that participants may select more than one
response option (for example, ‘tick all that apply’).
There is some evidence that answers to closed questions
are influenced by the values chosen by investigators for
each response category offered and that respondents
may avoid extreme categories [8]. Closed-ended ques-
tions where participants are asked to ‘tick all that apply’
can alternatively be presented as separate questions,
each with a ‘yes’ or ‘no’ response option (this design
may be suitable if the analysis planned will treat each
response category as a binary variable).
Asking participants subsidiary questions (that is,
‘branching off’) depending on their answers to core
questions will provide further detail about outcomes,
but will increase questionnaire length and could make a
questionnaire harder to follow. Similarly ‘matrix’ style
questions (that is, multiple questions with common
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response option categories) might seem complicated to
some participants, adding to the data collection burden
[9].
Style, appearance and layout
The way that a self-administered questionnaire looks is
considered to be as important as the questions that are
asked [9,10]. There is good evidence that in addition to
the words that appear on the page (verbal language) the
questionnaire communicates meaning and instructions
to participants via symbols and graphical features (non-
verbal language). The evidence from several RCTs of
alternative question response styles and layouts suggests
that participants view the middle (central) response
option as the one that represents the midpoint of an
outcome scale. Participants then expect response
options to appear in an order of increasing or decreas-
ing progression, beginning with the leftmost or upper-
most category; and they expect response options that
are closer to each other to also have values that are
‘conceptually closer’. The order, spacing and grouping of
response options are therefore important design fea-
tures, as they will affect the quality of data provided on
the questionnaire, and the time taken by participants to
provide it [10].
Some attempts have been made to develop theory-
based guidelines for self-administered questionnaire
design [11]. Based on a review of psychological and
sociological theories about graphic language, cognition,
visual perception and motivation, five principles have
been derived:
’Use the visual elements of brightness, colour, shape,
and location in a consistent manner to define the
desired navigational path for respondents to follow
when answering the questionnaire;
When established format conventions are changed in
the midst of a questionnaire use prominent visual guides
to redirect respondents;
Place directions [instructions] where they are to be
used and where they can be seen;
Present information in a manner that does not require
respondents to connect information from separate loca-
tions in order to comprehend it;
Ask people to answer only one question at a time’
[11].
Adherence to these principles may help to ensure that
when participants complete a questionnaire they under-
stand what is being asked, how to give their response,
and which question to answer next. This will help parti-
cipants to give all the information being sought and
reduce the chances that they become confused or fru-
strated when completing the questionnaire. These prin-
ciples require evaluation in RCTs.
Font size and colour may further affect the legibility of
a questionnaire, which may also impact on data quality
and completeness. Questionnaires for trials that enrol
older participants may therefore require the use of a lar-
ger font (for example, 11 or 12 point minimum) than
those for trials including younger participants. The leg-
ibility and comprehension of the questionnaire can be
assessed during the pilot phase (see section on piloting
below).
Perhaps most difficult to define are the factors that
make a questionnaire more aesthetically pleasing to par-
ticipants, and that may potentially increase compliance.
The use of space, graphics, underlining, bold type, col-
our and shading, and other qualities of design may affect
how participants react and engage with a questionnaire.
Edward Tufte’s advice for achieving graphical excellence
[12] might be adapted to consider how to achieve excel-
lence in questionnaire design, viz: ask the participant
the simplest, clearest questions in the shortest time
using the fewest words on the fewest pages; above all
else ask only what you need to know.
Further research is therefore needed (as will be seen in
the section on increasing data completeness) into the
types of question and the aspects of style, appearance
and layout of questionnaires that are effective in increas-
ing data quality and completeness.
Mode of administration
Self-administered questionnaires are usually cheaper to
use as they require no investigator input other than that
for their distribution. Mailed questionnaires require cor-
rect addresses to be available for each participant, and
resources to cover the costs of delivery. Electronically
distributed questionnaires require correct email
addresses as well as access to computers and the inter-
net. Mailed and electronically distributed questionnaires
have the advantage that they give participants time to
think about their responses to questions, but they may
require assistance to be available for participants (for
example, a telephone helpline).
As self-administered questionnaires have least investi-
gator involvement they are less susceptible to informa-
tion bias (for example, social desirability bias) and
interviewer effects, but are more susceptible to item
non-response [8]. Evidence from a systematic review of
57 studies comparing self-reported versus clinically veri-
fied compliance with treatment suggests that question-
naires and diaries may be more reliable than interviews
[13].
In-person administration allows a rapport with partici-
pants to be developed, for example through eye contact,
active listening and body language. It also allows inter-
viewers to clarify questions and to check answers. Tele-
phone administration may still provide the aural
dimension (active listening) of an in-person interview. A
possible disadvantage of telephone interviews is that
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participants may become distracted by other things
going on around them, or decide to end the call [9].
A mixture of modes of administration may also be
considered: for example, participant follow-up might
commence with postal or email administration of the
questionnaire, with subsequent telephone calls to non-
respondents. The offer of an in-person interview may
also be necessary, particularly if translation to a second
language is required, or if participants are not suffi-
ciently literate. Such approaches may risk introducing
selection bias if participants in one treatment group are
more or less likely than the other group to respond to
one mode of administration used (for example, tele-
phone follow-up in patients randomised to a new type
of hearing aid) [14].
An advantage of electronic and web-based question-
naires is that they can be designed automatically to
screen and filter participant responses. Movement from
one question to the next can then appear seamless,
reducing the data collection burden on participants who
are only asked questions relevant to previous answers.
Embedded algorithms can also check the internal con-
sistency of participant responses so that data are intern-
ally valid when submitted, reducing the need for data
queries to be resolved later. However, collection of data
from participants using electronic means may discrimi-
nate against participants without access to a computer
or the internet. Choice of mode of administration must
therefore take into account its acceptability to partici-
pants and any potential for exclusion of eligible partici-
pants that may result.
Piloting
Piloting is a process whereby new questionnaires are
tested, revised and tested further before they are used in
the main trial. It is an iterative process that usually
begins by asking other researchers who have some
knowledge and experience in a similar field to comment
on the first draft of the questionnaire. Once the ques-
tionnaire has been revised, it can then be piloted in a
non-expert group, such as among colleagues. A further
revision of the questionnaire can be piloted with indivi-
duals who are representative of the population who will
complete it in the main trial. In-depth ‘cognitive inter-
viewing’ might also provide insights into how partici-
pants comprehend questions, process and recall
information, and decide what answers to give [15]. Here
participants are read each question and are either asked
to ‘think aloud’ as they consider what their answer will
be, or are asked further ‘probing’ questions by the
interviewer.
For international multicentre trials it will be necessary
to translate a questionnaire. Although a simple transla-
tion to, and translation back from the second language
might be sufficient, further piloting and cognitive
interviews may be required to identify and correct for
any cultural differences in interpretation of the trans-
lated questionnaire. Translation into other languages
may alter the layout and formatting of words on the
page from the original design and so further redesign of
the questionnaire may be required. If a questionnaire is
to be developed for a clinical trial, sufficient resources
are therefore required for its design, piloting and
revision.
Increasing data completeness
Loss to follow-up will reduce statistical power by redu-
cing the effective sample size. Losses may also introduce
bias if the trial treatment is an effect modifier for the
association between outcome and participation at fol-
low-up [16].
There may be exceptional circumstances for allowing
participants to skip certain questions (for example, sen-
sitive questions on sexual lifestyle) to ensure that the
remainder of the questionnaire is still collected; the data
that are provided may then be used to impute the values
of variables that were not provided. Although the impact
of missing outcome data and missing covariates on
study results can be reduced through the use of multiple
imputation techniques, no method of analysis can be
expected to overcome them completely [17].
Length
Longer and more demanding tasks might be expected to
have fewer volunteers than shorter, easier tasks. The evi-
dence from randomised trials of questionnaire length in
a range of settings seems to support the notion that
when it comes to questionnaire design ‘shorter is better’
[18]. Recent evidence that a longer questionnaire
achieved the same high response proportion as that of a
shorter alternative might cast doubt on the importance
of the number of questions included in a questionnaire
[19]. However, under closer scrutiny the results of this
study (96.09% versus 96.74%) are compatible with an
average 2% reduction in odds of response for each addi-
tional page added to the shorter version [18]. The main
lesson seems to be that when the baseline response pro-
portion is very high (for example, over 95%) then few
interventions are likely to have effects large enough to
increase it further.
There is a trade off between increased measurement
error from using a simplified outcome scale and
increased power from achieving measurement on a lar-
ger sample of participants (from fewer losses to follow-
up). If a shorter version of an outcome scale provides
measures of an outcome that are highly correlated with
the longer version, then it will be more efficient for the
trial to use the shorter version [1]. A moderate reduc-
tion to the length of a shorter questionnaire will be
more effective in reducing losses to follow-up than a
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moderate change to the length of a longer questionnaire
[18].
In studies that seek to collect information on many
outcomes, questionnaire length will necessarily be deter-
mined by the number of items required from each parti-
cipant. In very compliant populations there may be little
lost by using a longer questionnaire. However, using a
longer questionnaire to measure more outcomes may
also increase the risk of false positive findings that result
from multiple testing (for example, measuring 100 out-
comes may produce 5 that are significantly associated
with treatment by chance alone) [4,20].
Other strategies to increase completeness
A recently updated Cochrane systematic review presents
evidence from RCTs of methods to increase response to
postal and electronic questionnaires in a range of health
and non-health settings [3]. The review includes 481
trials that evaluated 110 different methods for increasing
response to postal questionnaires and 32 trials that eval-
uated 27 methods for increasing response to electronic
questionnaires. The trials evaluate aspects of question-
naire design, the introductory letter, packaging and
methods of delivery that might influence the tendency
for participants to open the envelope (or email) and to
engage with its contents. A summary of the results
follows.
What participants are offered
Postal questionnaires
The evidence favours offering monetary incentives and
suggests that money is more effective than other types
of incentive (for example, tokens, lottery tickets, pens,
and so on). The relationship between the amount of
monetary incentive offered and questionnaire response
is non-linear with diminishing marginal returns for each
additional amount offered [21]. Unconditional incentives
appear to be more effective, as are incentives offered
with the first rather than a subsequent mailing. There is
less evidence for the effects of offering the results of the
study (when complete) or offering larger non-monetary
incentives.
Electronic questionnaires
The evidence favours non-monetary incentives (for
example, Amazon.com gift cards), immediate notifica-
tion of lottery results, and offering study results. Less
evidence exists for the effect of offering monetary rather
than non-monetary incentives.
How questionnaires look
Postal
The evidence favours using personalised materials, a
handwritten address, and printing single sided rather
than double sided. There is also evidence that inclusion
of a participant’s name in the salutation at the start of
the cover letter increases response and that the addition
of a handwritten signature on letters will further
increase response [22]. There is less evidence for posi-
tive effects of using coloured or higher quality paper,
identifying features (for example, identity number),
study logos, brown envelopes, coloured ink, coloured
letterhead, booklets, larger paper, larger fonts, pictures
in the questionnaire, matrix style questions, or questions
that require recall in order of time period.
Electronic
The evidence favours using a personalised approach, a
picture in emails, a white background for emails, a sim-
ple header, and textual rather than a visual presentation
of response categories. Response may be reduced when
‘survey’ is mentioned in the subject line. Less evidence
exists for sending emails in text format or HTML,
including a topic in email subject lines, or including a
header in emails.
How questionnaires are received or returned
Postal
The evidence favours sending questionnaires by first
class or recorded delivery, using stamped return envel-
opes, and using several stamps. There is less evidence
for effects of mailing soon after discharge from hospital,
mailing or delivering on a Monday, sending to work
addresses, using stamped outgoing envelopes (rather
than franked), using commemorative or first class
stamps on return envelopes, including a prepaid return
envelope, using window or larger envelopes, or offering
the option of response by internet.
Methods and number of requests for participation
Postal
The evidence favours contacting participants before
sending questionnaires, follow-up contact with non-
responders, providing another copy of the questionnaire
at follow-up and sending text message reminders rather
than postcards. There is less evidence for effects of pre-
contact by telephone rather than by mail, telephone fol-
low-up rather than by mail, and follow-up within a
month rather than later.
Nature and style of questions included
Postal
The evidence favours placing more relevant questions
and easier questions first, user friendly and more inter-
esting or salient questionnaires, horizontal orientation of
response options rather than vertical, factual questions
only, and including a ‘teaser’. Response may be reduced
when sensitive questions are included or when a ques-
tionnaire for carers or relatives is included. There is less
evidence for asking general questions or asking for
demographic information first, using open-ended rather
than closed questions, using open-ended questions first,
including ‘don’t know’ boxes, asking participants to ‘cir-
cle answer’ rather than ‘tick box’, presenting response
options in increasing order, using a response scale with
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5 levels rather than 10 levels, or including a supplemen-
tal questionnaire or a consent form.
Electronic
The evidence favours using a more interesting or salient
e-questionnaire.
Who sent the questionnaire
Postal
The evidence favours questionnaires that originate from
a university rather than government department or
commercial organisation. Less evidence exists for the
effects of precontact by a medical researcher (compared
to non-medical), letters signed by more senior or well
known people, sending questionnaires in university-
printed envelopes, questionnaires that originate from a
doctor rather than a research group, names that are eth-
nically identifiable, or questionnaires that originate from
male rather than female investigators.
Electronic
The evidence suggests that response is reduced when e-
questionnaires are signed by male rather than female
investigators. There is less evidence for the effectiveness
of e-questionnaires originating from a university or
when sent by more senior or well known people.
What participants are told
Postal
The evidence favours assuring confidentiality and men-
tioning an obligation to respond in follow-up letters.
Response may be reduced when endorsed by an ‘emi-
nent professional’ and requesting participants to not
remove ID codes. Less evidence exists for the effects of
stating that others have responded, a choice to opt out
of the study, providing instructions, giving a deadline,
providing an estimate of completion time, requesting a
telephone number, stating that participants will be con-
tacted if they do not respond, requesting an explanation
for non-participation, an appeal or plea, requesting a
signature, stressing benefits to sponsor, participants or
society, or assuring anonymity rather than participants
being identifiable.
Electronic
The evidence favours stating that others have responded
and giving a deadline. There is less evidence for the
effect of an appeal (for example, ‘request for help’) in
the subject line of an email.
So although uncertainty remains about whether some
strategies increase data completeness there is sufficient
evidence to produce some guidelines. Where there is a
choice, a shorter questionnaire can reduce the size of
the task and burden on respondents. Begin a question-
naire with the easier and most relevant questions, and
make it user friendly and interesting for participants. A
monetary incentive can be included as a little unex-
pected ‘thank you for your time’. Participants are more
likely to respond with advance warning (by letter, email
or phone call in advance of being sent a questionnaire).
This is a simple courtesy warning participants that they
are soon to be given a task to do, and that they may
need to set some time aside to complete it. The rele-
vance and importance of participation in the trial can be
emphasised by addressing participants by name, signing
letters by hand, and using first class postage or recorded
delivery. University sponsorship may add credibility, as
might the assurance of confidentiality. Follow-up con-
tact and reminders to non-responders are likely to be
beneficial, but include another copy of the questionnaire
to save participants having to remember where they put
it, or if they have thrown it away.
The effects of some strategies to increase question-
naire response may differ when used in a clinical trial
compared with a non-health setting. Around half of
trials included in the Cochrane review were health
related (patient groups, population health surveys and
surveys of healthcare professionals). The other included
trials were conducted among business professionals,
consumers, and the general population. To assess
whether the size of the effects of each strategy on ques-
tionnaire response differ in health settings will require a
sufficiently sophisticated analysis that controls for cov-
ariates (for example, number of pages in the question-
naire, use of incentives, and so on). Unfortunately, these
details are seldom included by investigators in the pub-
lished reports [3].
However, a review of 15 RCTs of methods to increase
response in healthcare professionals and patients found
evidence for using some strategies (for example, shorter
questionnaires and sending reminders) in the health-
related setting [23]. There is also evidence that incen-
tives do improve questionnaire response in clinical trials
[24,25]. The offer of monetary incentives to participants
for completion of a questionnaire may, however, be
unacceptable to some ethics committees if they are
deemed likely to exert pressure on individuals to partici-
pate [26]. Until further studies establish whether other
strategies are also effective in the clinical trial setting,
the results of the Cochrane review may be used as
guidelines for improving data completeness. More dis-
cussion on the design and administration of question-
naires is available elsewhere [27].
Risk factors for loss to follow-up
Irrespective of questionnaire design it is possible that
some participants will not respond because: (a) they
have never received the questionnaire or (b) they no
longer wish to participate in the study. An analysis of
the information collected at randomisation can be used
to identify any factors (for example, gender, severity of
condition) that are predictive of loss to follow-up [28].
Follow-up strategies can then be tailored for those parti-
cipants most at risk of becoming lost (for example,
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additional incentives for ‘at risk’ participants). Interviews
with a sample of responders and non-responders may
also identify potential improvements to the question-
naire design, or to participant information. The need for
improved questionnaire saliency, explanations of trial
procedures, and stressing the importance of responding
have all been identified using this method [29].
Further research
Few clinical trials appear to have nested trials of meth-
ods that might increase the quality and quantity of the
data collected by questionnaire, and of participation in
trials more generally. Trials of alternative strategies that
may increase the quality and quantity of data collected
by questionnaire in clinical trials are needed. Reports of
these trials must include details of the alternative instru-
ments used (for example, number of items, number of
pages, opportunity to save data electronically and
resume completion at another time), mean or median
time to completion of electronic questionnaires, material
costs and the amount of staff time required. Data collec-
tion in clinical trials is costly, and so care is needed to
design data collection instruments that will provide suf-
ficiently reliable measures of outcomes whilst ensuring
high levels of follow-up. Whether shorter ‘quick and
dirty’ outcome measures (for example, a few simple
questions) are better than more sophisticated question-
naires will require assessment of the costs in terms of
their impact on bias, precision, trial completion time,
and overall costs.
Conclusion
A good questionnaire design for a clinical trial will
minimise bias and maximise precision in the estimates
of treatment effect within budget. Attempts to collect
more data than will be analysed may risk reducing
recruitment (reducing power) and increasing losses to
follow-up (possibly introducing bias). Questionnaire
design still does remain as much an art as a science, but
the evidence base for improving the quality and comple-
teness of data collection in clinical trials is growing.
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